189 related articles for article (PubMed ID: 25346275)
1. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.
Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB
J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275
[TBL] [Abstract][Full Text] [Related]
2. Effects of immunoadsorption and subsequent immunoglobulin G substitution on cardiopulmonary exercise capacity in patients with dilated cardiomyopathy.
Herda LR; Trimpert C; Nauke U; Landsberger M; Hummel A; Beug D; Kieback A; Dörr M; Empen K; Knebel F; Ewert R; Angelow A; Hoffmann W; Felix SB; Staudt A
Am Heart J; 2010 May; 159(5):809-16. PubMed ID: 20435190
[TBL] [Abstract][Full Text] [Related]
3. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
[TBL] [Abstract][Full Text] [Related]
4. Immunoadsorption in dilated cardiomyopathy: 6-month results from a randomized study.
Staudt A; Hummel A; Ruppert J; Dörr M; Trimpert C; Birkenmeier K; Krieg T; Staudt Y; Felix SB
Am Heart J; 2006 Oct; 152(4):712.e1-6. PubMed ID: 16996843
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry.
Ohlow MA; Brunelli M; Schreiber M; Lauer B
J Cardiol; 2017 Feb; 69(2):409-416. PubMed ID: 27890513
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
[TBL] [Abstract][Full Text] [Related]
7. Reduction of morbidity by immunoadsorption therapy in patients with dilated cardiomyopathy.
Knebel F; Böhm M; Staudt A; Borges AC; Tepper M; Jochmann N; Wernicke KD; Felix S; Baumann G
Int J Cardiol; 2004 Dec; 97(3):517-20. PubMed ID: 15561342
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study.
Felix SB; Staudt A; Dörffel WV; Stangl V; Merkel K; Pohl M; Döcke WD; Morgera S; Neumayer HH; Wernecke KD; Wallukat G; Stangl K; Baumann G
J Am Coll Cardiol; 2000 May; 35(6):1590-8. PubMed ID: 10807465
[TBL] [Abstract][Full Text] [Related]
9. A pilot study to assess the use of protein a immunoadsorption for chronic dilated cardiomyopathy.
Cooper LT; Belohlavek M; Korinek J; Yoshifuku S; Sengupta PP; Burgstaler EA; Winters JL
J Clin Apher; 2007; 22(4):210-4. PubMed ID: 17385721
[TBL] [Abstract][Full Text] [Related]
10. Immunoadsorption in patients with dilated cardiomyopathy.
Herda LR; Felix SB; Staudt A
Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
[TBL] [Abstract][Full Text] [Related]
11. Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy.
Ameling S; Herda LR; Hammer E; Steil L; Teumer A; Trimpert C; Dörr M; Kroemer HK; Klingel K; Kandolf R; Völker U; Felix SB
Eur Heart J; 2013 Mar; 34(9):666-75. PubMed ID: 23100283
[TBL] [Abstract][Full Text] [Related]
12. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
[TBL] [Abstract][Full Text] [Related]
13. Ig apheresis for the treatment of severe DCM patients.
Pokrovsky SN; Ezhov MV; Safarova MS; Saidova MA; Shitov VN; Afanasieva MI; Khaustov AI; Adamova IY; Afanasieva OI; Konovalov GA
Atheroscler Suppl; 2013 Jan; 14(1):213-8. PubMed ID: 23357167
[TBL] [Abstract][Full Text] [Related]
14. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
Dandel M; Wallukat G; Englert A; Lehmkuhl HB; Knosalla C; Hetzer R
Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
[TBL] [Abstract][Full Text] [Related]
15. Immunoadsorption therapy for dilated cardiomyopathy using tryptophan column-A prospective, multicenter, randomized, within-patient and parallel-group comparative study to evaluate efficacy and safety.
Yoshikawa T; Baba A; Akaishi M; Wakabayashi Y; Monkawa T; Kitakaze M; Izumi T; Tomoike H
J Clin Apher; 2016 Dec; 31(6):535-544. PubMed ID: 26801483
[TBL] [Abstract][Full Text] [Related]
16. Specific immunoadsorption therapy using a tryptophan column in patients with refractory heart failure due to dilated cardiomyopathy.
Nagatomo Y; Baba A; Ito H; Naito K; Yoshizawa A; Kurita Y; Nakamura I; Monkawa T; Matsubara T; Wakabayashi Y; Ogawa S; Akaishi M; Yoshikawa T
J Clin Apher; 2011; 26(1):1-8. PubMed ID: 21312253
[TBL] [Abstract][Full Text] [Related]
17. Role of immunoglobulin G3 subclass in dilated cardiomyopathy: results from protein A immunoadsorption.
Staudt A; Dörr M; Staudt Y; Böhm M; Probst M; Empen K; Plötz S; Maschke HE; Hummel A; Baumann G; Felix SB
Am Heart J; 2005 Oct; 150(4):729-36. PubMed ID: 16209975
[TBL] [Abstract][Full Text] [Related]
18. Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution.
Staudt A; Schäper F; Stangl V; Plagemann A; Böhm M; Merkel K; Wallukat G; Wernecke KD; Stangl K; Baumann G; Felix SB
Circulation; 2001 Jun; 103(22):2681-6. PubMed ID: 11390337
[TBL] [Abstract][Full Text] [Related]
19. The number of regulatory T cells correlates with hemodynamic improvement in patients with inflammatory dilated cardiomyopathy after immunoadsorption therapy.
Bulut D; Creutzenberg G; Mügge A
Scand J Immunol; 2013 Jan; 77(1):54-61. PubMed ID: 22998220
[TBL] [Abstract][Full Text] [Related]
20. Potential role of humoral immunity in cardiac dysfunction of patients suffering from dilated cardiomyopathy.
Staudt A; Staudt Y; Dörr M; Böhm M; Knebel F; Hummel A; Wunderle L; Tiburcy M; Wernecke KD; Baumann G; Felix SB
J Am Coll Cardiol; 2004 Aug; 44(4):829-36. PubMed ID: 15312867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
